• Composition : Palbociclib
  • Manufacturer: Everest
  • Indication: Breast Cancer
  • Packaging: 21 Caps
  • Dosage Form: Capsule


  • 125mg


Brand name – Palboxen

Generic name – Palbociclib

Manufacturer – Everest

Strength – 125mg

Dosage Form – Capsules

Composition – Palbociclib

Indication – Breast Cancer

Storage – at 20° – 25° C

Overview Of Palboxen 125mg Capsule

Palboxen 125 mg capsules is a target therapy medication that is used to treat breast cancer. The generic name of this medication is Palbociclib. It is a cyclin-dependent kinase inhibitor that showcases antineoplastic properties. It is based on a prescription and should be taken with food. Also, inform the doctor about all the necessary details regarding past medical history.


Palboxen 125mg is a piperazine pyridopyrimidine and is a cyclin-dependent kinase (CDK4/6) inhibitor. It functions by binding to the ATP pocket and inhibiting the cell division process. Therefore it shows anti-tumour activity by blocking the cell division of the cancerous cells. In addition, it stops the spreading of the tumours throughout the body.

Side Effects

  • Diarrhea
  • Vomiting
  • Loss of appetite
  • Extreme fatigue
  • Dizziness
  • Dry skin
  • Rashes
  • Irregular heartbeat
  • Nosebleeds
  • Increased bruises
  • Hair loss
  • Tingling of arms and feet
  • Shortness of breath


Palboxen 125 mg capsules is a prescription-based medication and it should be taken one time every day with food.

Missed dose

It is advisable to avoid missing any doses. In case you miss a dose of Palboxen consult your doctor immediately.


In case of an overdose of Palboxen 125mg, contact your doctor or any healthcare provider and seek medical attention immediately.


  • Palboxen can cause an allergic reaction in some patients thus it is important to gather complete information about the tablets before starting the treatment.
  • Inform the doctor about all the prescription, and non-prescription medicines and vitamins that you take since Palboxen can interact with them and hinder their function.
  • It is advisable to avoid pregnancy and breastfeeding during and 3 weeks after the last dose since Palboxen can cause harm to the fetus.
  • Palboxen 125 mg capsules is a prescription-based medication that decreases fertility in male patients. Also, patients with female partners should avoid pregnancy till three months after the last dose.
  • It is advisable to avoid alcohol and driving the treatment with Palboxen.
  • Palboxen can often interact with some diseases like – liver and kidney impairments.